ICON Appoints New Chief Medical Officer

08:30am, Tuesday, 05'th May 2020
ICON plc, (NASDAQ: ICLR) a leading global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced tha
Icon Plc (NASDAQ:ICLR) – Stock analysts at SunTrust Banks dropped their Q4 2020 earnings estimates for shares of Icon in a research note issued on Monday, April 27th. SunTrust Banks analyst S. Drape
GW Henssler & Associates Ltd. lessened its position in shares of Icon Plc (NASDAQ:ICLR) by 3.4% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm ow
Envestnet Asset Management Inc. trimmed its holdings in Icon Plc (NASDAQ:ICLR) by 0.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 203,207 shares of the medical
Icon (NASDAQ:ICLR) was downgraded by research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued on Tuesday, BidAskClub reports. ICLR has been the topic
Icon Plc (NASDAQ:ICLR) – Investment analysts at KeyCorp decreased their FY2021 earnings per share estimates for shares of Icon in a research note issued to investors on Thursday, April 23rd. KeyCorp
Icon Plc (NASDAQ:ICLR) – Analysts at William Blair dropped their Q2 2020 earnings per share (EPS) estimates for Icon in a research note issued to investors on Thursday, April 23rd. William Blair ana

ICON (ICLR) Q1 2020 Earnings Call Transcript

01:01am, Friday, 24'th Apr 2020
ICLR earnings call for the period ending March 31, 2020.
ICON Public Limited Company (NASDAQ:ICLR) Q1 2020 Results Conference Call April 23, 2020 09:00 AM ET Company Participants Jonathan Curtain - VP, Corporate Finan
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE